Bionano Genomics BNGO is set to give its latest quarterly earnings report on Monday, 2025-03-31. Here's what investors need to know before the announcement.
Analysts estimate that Bionano Genomics will report an earnings per share (EPS) of $-8.40.
The announcement from Bionano Genomics is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It's worth noting for new investors that guidance can be a key determinant of stock price movements.
Historical Earnings Performance
Last quarter the company missed EPS by $18.60, which was followed by a 7.58% drop in the share price the next day.
Here's a look at Bionano Genomics's past performance and the resulting price change:
Quarter | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
---|---|---|---|---|
EPS Estimate | -12.6 | -25.2 | -38.4 | -52.2 |
EPS Actual | -31.2 | -14.4 | -36 | -57.6 |
Price Change % | -8.0% | -7.000000000000001% | 7.000000000000001% | 2.0% |
Stock Performance
Shares of Bionano Genomics were trading at $3.07 as of March 27. Over the last 52-week period, shares are down 95.36%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release.
To track all earnings releases for Bionano Genomics visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.